Published in Med Phys on July 01, 2013
Use dose bricks concept to implement nasopharyngeal carcinoma treatment planning. Biomed Res Int (2014) 0.79
Optimization approaches to volumetric modulated arc therapy planning. Med Phys (2015) 0.77
An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer. Biomed Res Int (2015) 0.75
Optimization of rotational arc station parameter optimized radiation therapy. Med Phys (2016) 0.75
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT. Radiother Oncol (2009) 2.26
Bridging the gap between IMRT and VMAT: dense angularly sampled and sparse intensity modulated radiation therapy. Med Phys (2011) 2.18
Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother Oncol (2009) 2.00
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Volumetric-modulated arc therapy for stereotactic body radiotherapy of lung tumors: a comparison with intensity-modulated radiotherapy techniques. Int J Radiat Oncol Biol Phys (2011) 1.55
Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys (2011) 1.34
SmartArc-based volumetric modulated arc therapy for oropharyngeal cancer: a dosimetric comparison with both intensity-modulated radiation therapy and helical tomotherapy. Int J Radiat Oncol Biol Phys (2010) 1.29
Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery. Int J Radiat Oncol Biol Phys (2010) 1.26
Comparing radiation treatments using intensity-modulated beams, multiple arcs, and single arcs. Int J Radiat Oncol Biol Phys (2010) 1.25
The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer--a planning study. Radiother Oncol (2011) 1.12
Improving IMRT delivery efficiency using intensity limits during inverse planning. Med Phys (2005) 1.05
Clinical significance of multi-leaf collimator positional errors for volumetric modulated arc therapy. Radiother Oncol (2010) 1.01
Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma. Radiother Oncol (2011) 0.99
RapidArc radiation therapy: first year experience at the University of Alabama at Birmingham. Int J Radiat Oncol Biol Phys (2010) 0.96
The ArcCHECK diode array for dosimetric verification of HybridArc. Phys Med Biol (2011) 0.91
HybridArc: a novel radiation therapy technique combining optimized dynamic arcs and intensity modulation. Med Dosim (2012) 0.86
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol (2002) 3.89
Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys (2002) 3.64
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys (2005) 3.32
Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys (2010) 2.69
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys (2003) 2.41
Radiation-associated liver injury. Int J Radiat Oncol Biol Phys (2010) 2.39
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol (2005) 2.20
Partial volume tolerance of the liver to radiation. Semin Radiat Oncol (2005) 1.85
Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys (2010) 1.74
Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys (2009) 1.64
Mutual information based CT registration of the lung at exhale and inhale breathing states using thin-plate splines. Med Phys (2004) 1.55
Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys (2005) 1.55
A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol (2007) 1.55
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.52
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys (2005) 1.49
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys (2005) 1.38
Lexicographic ordering: intuitive multicriteria optimization for IMRT. Phys Med Biol (2007) 1.38
Dose reconstruction in deforming lung anatomy: dose grid size effects and clinical implications. Med Phys (2005) 1.36
Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys (2011) 1.33
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28
Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol (2002) 1.22
A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys (2008) 1.22
Parotid gland function after radiotherapy: the combined michigan and utrecht experience. Int J Radiat Oncol Biol Phys (2010) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Guest editor's introduction to QUANTEC: a users guide. Int J Radiat Oncol Biol Phys (2010) 1.20
Verification of dynamic and segmental IMRT delivery by dynamic log file analysis. J Appl Clin Med Phys (2002) 1.18
Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.18
Reduction of IMRT beam complexity through the use of beam modulation penalties in the objective function. Med Phys (2007) 1.17
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 1.14
How extensive of a 4D dataset is needed to estimate cumulative dose distribution plan evaluation metrics in conformal lung therapy? Med Phys (2007) 1.13
Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys (2002) 1.11
Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys (2005) 1.11
4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors. Int J Radiat Oncol Biol Phys (2013) 1.10
Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol (2007) 1.10
Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys (2007) 1.08
A method for incorporating organ motion due to breathing into 3D dose calculations in the liver: sensitivity to variations in motion. Med Phys (2003) 1.08
Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol (2005) 1.08
Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys (2010) 1.07
4π non-coplanar liver SBRT: a novel delivery technique. Int J Radiat Oncol Biol Phys (2012) 1.06
Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol (2004) 1.06
A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study. Med Phys (2003) 1.06
Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. J Oncol Pract (2013) 1.05
A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys (2009) 1.05
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res (2011) 1.05
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys (2012) 1.05
Improving IMRT delivery efficiency using intensity limits during inverse planning. Med Phys (2005) 1.05
Synchronized dynamic dose reconstruction. Med Phys (2007) 1.03
Safety considerations for IMRT: executive summary. Med Phys (2011) 1.02
Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions. Med Phys (2007) 1.01
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys (2005) 1.01
An exact approach to direct aperture optimization in IMRT treatment planning. Phys Med Biol (2007) 1.00
Alterations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys (2003) 1.00
Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys (2012) 0.99
Ultrafast treatment plan optimization for volumetric modulated arc therapy (VMAT). Med Phys (2010) 0.99
A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization. Med Phys (2005) 0.98
A practical approach for quantitative estimates of voxel-by-voxel liver perfusion using DCE imaging and a compartmental model. Med Phys (2006) 0.98
Comparative analysis of 60Co intensity-modulated radiation therapy. Phys Med Biol (2008) 0.95
Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys (2005) 0.95
Adaptive diffusion smoothing: a diffusion-based method to reduce IMRT field complexity. Med Phys (2008) 0.95
Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys (2006) 0.95
Dosimetry around metallic ports in tissue expanders in patients receiving postmastectomy radiation therapy: an ex vivo evaluation. Med Dosim (2004) 0.94
Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT. J Radiat Oncol (2013) 0.93
A dose gradient analysis tool for IMRT QA. J Appl Clin Med Phys (2005) 0.92
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer (2004) 0.92
Incorporation of realistic delivery limitations into dynamic MLC treatment delivery. Med Phys (2002) 0.92
Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys (2002) 0.91
Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys (2004) 0.91
Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys (2002) 0.91
Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Int J Radiat Oncol Biol Phys (2005) 0.91
Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary. Pract Radiat Oncol (2013) 0.90
Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning. J Thorac Oncol (2011) 0.90
Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys (2004) 0.89
Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.89
A new column-generation-based algorithm for VMAT treatment plan optimization. Phys Med Biol (2012) 0.89
Adequacy of inhale/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT. Radiat Oncol (2014) 0.89
Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms. Int J Radiat Oncol Biol Phys (2012) 0.88
Experimental validation of the DPM Monte Carlo code using minimally scattered electron beams in heterogeneous media. Phys Med Biol (2002) 0.88
Evaluating target cold spots by the use of tail EUDs. Int J Radiat Oncol Biol Phys (2008) 0.87
Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors. Int J Radiat Oncol Biol Phys (2005) 0.87
Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2009) 0.86